Monthly Archives: January 2014
Best Practices in Structuring & Managing Early-Stage Commercialization Groups
The success of a pharmaceutical organization’s pipeline is often linked to the effectiveness of its new product commercialization function. Despite this, there is no consensus on what separates an effective early-stage commercialization group from an ineffective one. While the success
Propelling A Brand to #1 & Staying on Top
Although there are vast differences between various brands’ journeys to success, there are also some commonalities. Understanding these best practices can help leaders to propel their pharmaceutical brand to #1 and stay on top. So how does a brand become
Top 3 Challenges in Creating & Maintaining Effective Managed Care Pull-Through Programs
In today’s competitive marketplace, pull-through programs are increasing in importance and can be highly effective at driving results. In order to increase provider awareness of products, leaders must now ensure that their managed care pull-through programs and processes are effective
HOL Function Driving Value Across Healthcare Industry
Health Outcomes Liaisons (HOLs) serve as a scientific bridge between companies and health care system decision-makers in managed care. With billions in sales riding on effectively communicating with these organizations, HOLs are increasingly working to effectively convey a therapy’s safety
Emphasis on US Managed Care Organizations Increasing
The influence of Managed Care groups is increasing, causing leaders in the pharmaceutical industry to also increase the number of activities that they carry out as a part of interacting with the managed care sector. Pharmaceutical and biotech leaders have
Success Factors & Future Trends in Oncology-GSM
Successfully marketing a new oncology product can be a daunting endeavor that often falls to the Global Strategic Marketing function within the biopharmaceutical industry. Not only must these groups navigate a tough regulatory environment, but regional differences and the competitive